5-Hydroxypyrazinamide (BioDeep_00000027735)

   

human metabolite Endogenous Chemicals and Drugs


代谢物信息卡片


5-oxo-4,5-Dihydropyrazine-2-carboximidate

化学式: C5H5N3O2 (139.03817500000002)
中文名称: 5-羟基吡嗪羧酰胺
谱图信息: 最多检出来源 Bos taurus(endogenous) 80%

分子结构信息

SMILES: C1=C(N=CC(=O)N1)C(=O)N
InChI: InChI=1S/C5H5N3O2/c6-5(10)3-1-8-4(9)2-7-3/h1-2H,(H2,6,10)(H,8,9)

描述信息

Pyrazinamide. Pyrazinamide is a drug used to treat tuberculosis in afflicted patients. The drug is largely bacteriostatic, but can be bacteriocidal on actively replicating tuberculosis bacteria. -- Wikipedia; Pyrazinamide is a generic drug and is available in a wide variety of presentations. Pyrazinamide tablets are usually 500mg and form the bulkiest part of the standard tuberculosis treatment regimen. Pyrazinamide tablets are so large that some patients find them impossible to swallow: pyrazinamide syrup is an option for these patients. -- Wikipedia; Pyrazinamide is also available as part of fixed dose combinations with other TB drugs such as isoniazid and rifampicin (Rifater is an example). -- Wikipedia; Pyrazinamide is well absorbed orally. It crosses inflamed meninges and is an essential part of the treatment of tuberculous meningitis. It is metabolised by the liver and the metabolic products are excreted by the kidneys. -- Wikipedia; Pyrazinamide is a pro-drug that stops the growth of Mycobacterium tuberculosis. M. tuberculosis has the enzyme pyrazinamidase which is only active at acidic pH. Pyrazinamidase converts pyrazinamide to the active form, pyrazinoic acid. Pyrazinoic acid inhibits the enzyme fatty acid synthetase I, which is required by the bacterium to synthesise fatty acids. Mutations of the pyrazinamidase gene (pncA) are responsible for pyrazinamide resistance in M. tuberculosis. -- Wikipedia.
Pyrazinamide

同义名列表

8 个代谢物同义名

5-oxo-4,5-Dihydropyrazine-2-carboximidate; 5-oxo-4,5-dihydropyrazine-2-carboxamide; 5-Hydroxy-(8ci)-pyrazinecarboxamide; 6-oxo-1H-pyrazine-3-carboxamide; 5-oxo-4H-pyrazine-2-carboxamide; 2-carboxamido-5-Hydroxypyrazine; 5-Hydroxypyrazinecarboxamide; 5-Hydroxypyrazinamide



数据库引用编号

7 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • A Mehmedagic, P Vérité, S Ménager, C Tharasse, C Chabenat, D André, O Lafont. Determination of pyrazinamide and its main metabolites in rat urine by high-performance liquid chromatography. Journal of chromatography. B, Biomedical sciences and applications. 1997 Aug; 695(2):365-72. doi: 10.1016/s0378-4347(97)00175-8. [PMID: 9300873]
  • T Yamamoto, Y Moriwaki, S Takahashi, M Suda, K Higashino. Xylitol-induced increase in the concentration of oxypurines and its mechanism. International journal of clinical pharmacology and therapeutics. 1995 Jun; 33(6):360-5. doi: NULL. [PMID: 7582389]
  • C Lacroix, P Poncet, G Laine, C Guyonnaud, M Ray, S Menager, O Lafont. [Microdetermination of pyrazinamide and its metabolites (pyrazinoic acid, 5-hydroxypyrazinoic acid, 5-hydroxypyrazinamide and pyrazinuric acid) in plasma and urine with liquid chromatography]. Journal of chromatography. 1987 Nov; 422(?):217-25. doi: NULL. [PMID: 3437007]
  • T Yamamoto, Y Moriwaki, S Takahashi, T Hada, K Higashino. 5-Hydroxypyrazinamide, a human metabolite of pyrazinamide. Biochemical pharmacology. 1987 Jul; 36(14):2415-6. doi: 10.1016/0006-2952(87)90611-3. [PMID: 3606648]
  • L W Whitehouse, B A Lodge, A W By, B H Thomas. Metabolic disposition of pyrazinamide in the rat: identification of a novel in vivo metabolite common to both rat and human. Biopharmaceutics & drug disposition. 1987 Jul; 8(4):307-18. doi: 10.1002/bdd.2510080402. [PMID: 3620591]
  • E Beretta, S Botturi, P Ferrari, G Tuan, L F Zerilli. Identification of 5-hydroxypyrazinamide isolated from urine of subjects given pyrazinamide. Journal of chromatography. 1987 Apr; 416(1):144-9. doi: 10.1016/0378-4347(87)80495-4. [PMID: 3597630]
  • T Yamamoto, Y Moriwaki, S Takahashi, T Hada, K Higashino. Study of the metabolism of pyrazinamide using a high-performance liquid chromatographic analysis of urine samples. Analytical biochemistry. 1987 Feb; 160(2):346-9. doi: 10.1016/0003-2697(87)90058-3. [PMID: 3578761]